This study examines the biochemical properties of two members of the murine MSX family, MSX-l and MSX-2, which have been implicated to have partially overlapping functions during embryogenesis. Our analyses show that MSX-l and MSX-2 share many features in common including their DNA binding and transcriptional properties. In particular, MSX-l and MSX-2 interact with a common consensus DNA site, and exhibit similar DNA binding site preferences. However, MSX-2 has a higher apparent affinity for DNA, and the distinction between MSX-l and MSX-2 resides in their differing sequences N-terminal to the homeodomain. With respect to their transcriptional properties, both MSX-l and MSX-2 function as repressors and share the distinct property that they do so independently of their consensus DNA binding sites. However, MSX-l is a more potent repressor, and the difference between these proteins also maps to their N-terminal regions. Similarly, the expression patterns of Msx-l and Msx-2 as examined by whole mount in situ hybridization are related but not identical. Thus, Msx-l and Msx-2 are co-expressed in the limbs, neural tube, and branchial arches; however, Msx-l has a broader expression pattern overall and is expressed uniquely in certain embryonic regions. These features suggest that these members of the Msx family are 'equivalent but not equal' and that their proposed redundancy may be achieved via distinct biochemical mechanisms that yield a similar functional outcome.
Introduction
During vertebrate development, critical processes of patterning and differentiation must be regulated with high fidelity to ensure correct outcomes. It is now apparent that one mechanism for achieving such precision is through functional redundancy of regulatory proteins that are encoded by related genes (Thomas, 1993) . Indeed, many vertebrate transcription factors are encoded by members of gene families. Such related genes share one or more conserved motifs, such as their DNA binding domains, while often having only limited sequence identity elsewhere. Frequently, the various members of these related gene families share overlapping patterns of expression, and in some cases it has been demonstrated by targeted * Corresponding author. Tel.: +19082355161; fax: +19082354850. gene disruption that their functional properties are at least partially redundant.
We have been investigating the Msx family of vertebrate homeobox genes, which encode putative transcriptional regulatory proteins that are known to be important developmental regulators (Catron et aI., 1993 (Catron et aI., , 1995 Jabs et aI., 1993; Song et aI., 1992) . The Msx genes share a highly conserved homeobox motif that encodes a DNA binding domain. In the mouse, three Msx genes have been identified (Holland, 1991) , and two of these (Msx-l and Msx-2) have been cloned and characterized in detail (Hill et aI., 1989; Robert et aI., 1989; Monaghan et aI., 1991) . Despite their similar names, these two genes encode proteins that share limited sequence identity outside of the homeobox and regions directly flanking this motif (Fig. 1) . Although their primary sequences are not closely related, MSX-l and MSX-2 share certain K.M. Catron et at. I Mechanisms of Development 55 (1996) [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] Msx-1 22% A 14%G homeodomain
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Msx-2 features in common, including a relatively high percentage of prolines, glycines, and alanines ( Fig. 1) , residues that are prevalent in transcriptional regulatory proteins. Both Msx-1 and Msx-2 are expressed in a wide range of embryonic regions including the neural tube, the limb buds, and derivatives of the cranial neural crest (Hill et aI., 1989; Robert et aI., 1989 Robert et aI., , 1991 MacKenzie et aI., 1991a MacKenzie et aI., ,b, 1992 Suzuki et aI., 1991; Yokouchi et aI., 1991; Lyons et aI., 1992) . A common feature of these diverse zones of expression is their involvement in epithelialmesenchymal interactions (Brown et aI., 1993; Jowett et aI., 1993; Satokata and Maas, 1994; Wang and Sassoon, 1995) . Although these and other observations have implicated Msx genes as key developmental regulators, targeted disruption of Msx-1 results in no overt phenotype in many tissues where it is normally expressed (Satokata and Maas, 1994) . In fact, the only abnormalities observed in these null mutant mice are in tissues that derive from the first branchial arch, resulting in defects of the maxillary and mandibular bones and teeth (Satokata and Maas, 1994) . Consequently, one likely explanation for the limited severity of the Msx-1 null mutant phenotype is that co-expression of can compensate for the loss of function of Msx-1 .
We have undertaken a comparison of the biochemical properties and expression patterns of MSX-l and MSX-2. In a previous study, we have shown that MSX-l functions as a potent transcriptional repressor and that it has the distinct property of doing so independently of its homeodomain DNA binding activity (Catron et aI., 1995) . In this work, we extend these observations by demonstrating that MSX-l and MSX-2 have similar DNA binding and transcriptional properties, but that these functions are modulated differentially by their non-conserved Nterminal regions. Likewise, the overlapping expression patterns of Msx-l and Msx-2 display general similarities, but possess distinctive features in craniofacial and limb bud development. Therefore, we propose that MSX-l and MSX-2 function in an 'equivalent but not equal' manner, and that their proposed genetic redundancy may be achieved through dissimilar molecular mechanisms that can produce a similar functional outcome.
Results

The non-conserved N-terminal region confers higher DNA binding affinity for MSX-2 relative to MSX-1
Although the MSX-l homeodomain (MSX-l(l57-233)) binds specifically and with high affinity to a consensus DNA site which contains the motif CTAAITG, this DNA site is not required for transcriptional repression by MSX-l either in vitro or in vivo (Catron et aI., 1993 (Catron et aI., , 1995 . Given the possibility that the consensus site determined for the MSX-l homeodomain may not be utilized efficiently by the full length protein, we have examined the DNA binding properties of full length MSX-l and various truncated MSX-l polypeptides ( Fig. 2A, top) . To facilitate comparative analyses, the DNA binding properties of the full length MSX-2 and an analogous series of truncated MSX-2 polypeptides were also examined ( Fig. 2A, bottom) . The various proteins were purified in parallel and had similar stabilities in the DNA binding assays. The MSX protein preparations contained a majority of appropriately folded protein as determined by circular dichroism analysis (data not shown). The DNA binding properties of the MSX-l and MSX-2 polypeptides were tested by gel retardation assays using the consensus DNA site (CTAAITG), or other DNA sites which contained substitutions of nucleotides flanking the coli and purified by nickel-affinity chromatography. The purified polypeptides (2~g) were resolved on 13.5% SDSpolyacrylamide gels and visualized by staining with Coomassie brilliant blue. Markers correspond to molecular mass standards (Bio-Rad) in kiloDaltons (bovine serum albumin, 68 kDa; ovalbumin, 46 kDa; carbonic anhydrase, 31 kDa; soybean trypsin inhibitor, 20 kDa; and lysozyme, 14 kDa). essential TAAT core (Fig. 3A,B ). Our choice of DNA sites was based on a previous study, in which we showed that AT AA TTG, CT AA TT,C, and CT AA TQ were bound with varying affinities by MSX-l(157-233) (Catron et aI., 1993) . Inspection of gel retardation assays performed with full length MSX-l and the truncated polypeptides revealed that each polypeptide exhibited similar DNA binding specificity and binding site preferences to those previously described for (Fig.  3A) . Therefore, the DNA binding site preference for each of the MSX-l polypeptides was CTAATTG> ATAA TTG > CTAA TT,C, > CTAA TQ (Fig. 3A) . However, a noteworthy difference in the DNA binding properties of the various MSX-l proteins was their relative binding activities. Thus, the apparent binding activity of MSX-l and the various truncated polypeptides was reduced relative to that of the homeodomain alone (MSX-1(157-233); Fig. 2A ).
In the case of MSX-2, the full length protein and the truncated MSX-2 polypeptides exhibited similar DNA site preferences as those observed for MSX-l (Fig. 3B) . However, the full length MSX-2 protein exhibited greater relative DNA binding activity as compared to MSX-l ( Fig. 2A) . The difference between the relative binding activities of MSX-l and MSX-2 can be ascribed to sequences N-terminal to the homeodomain (compare A-C versus G-I in Fig. 2A ). Therefore, these DNA binding data show that MSX-l and MSX-2 exhibit identical DNA binding specificities and interact preferentially with the previously identified consensus DNA site. However, these results suggest that MSX-2 may have a higher apparent affinity for DNA due to its unique sequences Nterminal to the homeodomain.
To investigate this further we performed quantitative gel retardation assays to compare the relative DNA binding affinities of MSX-l, MSX-2 and the most pertinent truncated MSX polypeptides , and ; Fig. 4A,B) . Gel retardation assays were performed using a constant amount of the consensus DNA site and varying concentrations of each MSX protein (from 1 X 10-8 to 8 X 10-7 M) ( Fig.  4A ) As was evident from the gel retardation assay, the MSX proteins exhibited differences in their relative DNA binding affinity that were analogous to the results shown in Fig. 3 . Specifically, MSX-2 exhibited a greater relative affinity for DNA than MSX-l, and these differences were also apparent for the truncated polypeptides that contained the variant sequences N-terminal to the homeodomain (i.e. and MSX-2(90-207); Fig.  4A ). The inhibitory role imposed by the region Nterminal to the homeodomain of MSX-I was further evident since a polypeptide lacking this region (i.e. MSX-1(157-233)) had a relatively higher affinity for DNA than a polypeptide that contained this region ; Fig. 4A ). The differences in relative binding affinity among these various MSX polypeptides were also reflected in their apparent KdS which are shown in 4B). Protein-DNA complexes were formed with a constant amount of the radiolabelled DNA site and 2.7 X 10-7 M of each MSX polypeptide. Following incubation at room temperature for 10 min, increasing concentrations of unlabeled consensus DNA site (i.e. cold site 6) were added, and the incubation was continued for an additional 10 min. For each of the MSX polypeptides, the relative reduction in binding activity paralleled their apparent affinity as shown in Fig. 4A . Table 1 Relative Kd In summary, these findings demonstrate that MSX-2 has a higher relative affinity for the consensus DNA site than does MSX-l. Moreover, the difference between these two MSX proteins is attributed to their unique sequences residing N-terminal to the homeodomain wherein MSX-I, but not MSX-2, contains sequences that negatively influence its DNA binding affinity.
Both MSX-J and MSX-2function as repressors in the absence of homeodomain DNA binding sites
It is somewhat surprising that MSX-l does not utilize its high affinity consensus DNA binding site for its transcriptional repressor function (Catron et aI., 1995) . Because we had discovered this property of MSX-l in experiments using three tandem copies of the consensus DNA site (Catron et aI., 1995) , it was conceivable that the site-independence exhibited by MSX-l was due in part to the artificial template. Therefore, we have further examined the transcriptional properties of MSX-I using a re-porter plasmid contammg a genomic homeodomain binding site (lIer et aI., 1995) . This genomic site, termed WIP, was isolated from the Wnt-l enhancer and is required for the appropriate expression of a Wnt-l transgene in vivo (lIer et aI., 1995) .
We tested the transcriptional properties of MSX-l in transient transfection assays, using a reporter plasmid that contained the WIP element or a mutated version of the WIP element (m WIP) having point substitutions within the homeodomain site that abolish DNA binding (lIer et aI., 1995) . When tested in NIH 3T3 cells, MSX-l repressed transcription with equal effectiveness through both the WIP and mWIP reporter plasmids (Fig. 5A) . Repression through both reporter plasmids was concentration-dependent, with detectable levels (i.e., four-fold) observed using as little as 75 ng of the Msx-l expression plasmid (Fig. 5A) . These results are similar to those obtained previously using the reporter plasmid containing three tandem copies of the consensus DNA site (Catron et al., 1995) . These findings further demonstrate that MSX-l functions as a transcriptional repressor, and that homeodomain DNA binding sites are not required for this activity.
Using this transient transfection assay, we compared the transcriptional properties of MSX-2 with those of MSX-l. As shown in Fig. 5A , MSX-2 also functioned as a transcriptional repressor in NIH 3T3 cells. Moreover, similar levels of repression by MSX-2 were observed using either the WIP or mWIP reporter plasmids (Fig.  5A) . Therefore, MSX-2 also functions as a transcriptional repressor that is not dependent on homeodomain DNA binding sites. However, a notable difference between MSX-l and MSX-2 was their relative potency, since repression by MSX-l was twice as effective as that by MSX-2 (Fig. 5A) . Subsequent analyses (see below) confirmed that this is due to actual differences in repressor potency, rather than the lower apparent levels of MSX-2 expression observed in Western blot analysis (Fig.5B ).
Since MSX proteins do not require homeodomain binding sites for their repressor activity, it is likely that some other mechanism(s) directs MSX proteins to their appropriate targets. In lieu of knowing how MSX proteins are directed to specific promoters, we investigated their transcriptional properties when targeted to a heterologous promoter. For this purpose, we produced fusion polypeptides of MSX-l or MSX-2 with the Gal4 DNA binding domain, and examined their transcriptional properties using a reporter plasmid that contained the cognate Gal4 DNA binding sites (Fig. 5C ). When tested in this context, both the Gal4/MSX-l and GaI4/MSX-2 fusion proteins were potent transcriptional repressors (Fig. 5C ). In fact, repression was significantly enhanced in comparison to that obtained for the WIP element (compare Fig. 5A and 5C). Moreover, the GaI4/MSX proteins also repressed transcription from a reporter plasmid that lacked the Gal4 DNA binding sites, although repression was significantly lower (approximately five-to ten-fold) than that observed with the reporter plasmid containing the Gal4 sites (about 50-fold) (Fig. 5C ). These data demonstrate that MSX-l and MSX-2 function as transcriptional repressors even when directed to a heterologous DNA binding element. Furthermore, although homeodomain DNA binding sites are not required for MSX repressor function, these results suggest that directing these proteins to specific target sites significantly enhances their transcriptional properties.
The N-terminal domains of MSX-l and MSX-2 contribute differentially to their repressor activity
To determine the relative contribution of individual protein regions in MSX-l or MSX-2 to repressor function, we examined the activities of a series of polypeptides that contained various protein regions fused to the Gal4 DNA binding domain (Fig. 6A,B ). For these analyses, we subdivided the N-terminal regions of MSX-l and MSX-2 into three segments (designated I, II, or III), and Transfection assays were performed in NIH 3T3 cells using a luciferase reporter plasmid (2.ug) that contained the SV40 promoter (stippled box) and one copy of the WIP genomic fragment or a mutated WIP fragment (mWIP) (ller et al., 1995) . Expression plasmids contained sequences encoding the full-length MSX-l (pMsx-l) or MSX-2 (pMsx-2) and were included at the indicated amounts. Data are expressed as the fold-difference in luciferase activity obtained with the indicated expression plasmid relative to the activity obtained with the parental plasmid without insert. All transfection assays were repeated at least three times; a representative experiment is shown. Error bars show the difference between duplicates; variability among assays was in the range of 20%. (B) Western blot analysis was performed using extracts prepared from COS-l cells that were transfected with the expression plasmid without an insert (cell extract) or with the expression plasmids (O.5.ug) encoding the full-length MSX-l or MSX-2 polypeptides. The MSX-l antisera is directed against the homeodomain and recognizes both MSX-l and MSX-2 (Catron et al.. 1995; Catron and Abate-Shen, unpublished results) . (C) Transfection assays were performed in NIH 3T3 cells using a luciferase reporter plasmid (2.ug) that contained the SV40 promoter (stippled box) either alone or with five tandem copies of the Gal4 DNA binding site (5 x GaI4). Expression plasmids encoding the GaI4IMSX-1 (pgaI4/Msx-1) or the GaI4IMSX-2 (pgaI4/Msx-2) fusion polypeptides were included at 500 ng each. Data are expressed as the fold-difference in luciferase activity obtained with the indicated expression plasmid. relative to the activity obtained with the expression plasmid containing the Gal4 DNA binding domain alone. The boxed x-axis highlights the difference in scale between the two graphs. All transfection assays were repeated at least three times; a representative experiment is shown. Error bars show the difference between duplicates; variability among assays was in the range of 20%. (D) Western blot analysis was performed using extracts prepared from COS-l cells that were transfected using the expression plasmid without an MSX insert (cell extract) or using the expression plasmids (1.0.ug) encoding the Gal4IMSX-1 or GaI4IMSX-2 polypeptides. The anti-Gal4 monoclonal antibody (Santa Cruz Biologicals) is directed against an epitope within the Gal4 DNA binding domain. the C-terminal regions into two segments (designated IV and V). These divisions approximate regions of similarity between the two proteins, allowing for comparison of activity between the corresponding segments of MSX-l and MSX-2. The resulting Gal4IMSX fusion polypeptides contained one or more of these N-or C-terminal segments (Fig. 6A,B) . To examine the transcriptional properties of the Gal4IMSX polypeptides in distinct cell types, we :IE :E tested their activities in NIH 3T3 cells and in C2C12 cells using the reporter plasmid that contained the Gal4 DNA binding sites (Fig. 6A,B, top) . Interestingly, in contrast to our results obtained with full length GaI4IMSX-1 and GaI4IMSX-2, repression was not observed when the Gal4IMSX truncated polypeptides were tested using the reporter plasmid lacking Gal4 DNA binding sites (Catron et aI., 1995;  data not shown).
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The GaI4IMSX-1 fusion polypeptides that contained individual segments of the N-or C-terminal regions (i.e., I, II, III, IV or V) did not significantly repress transcription in either cell line tested (Fig. 6A) . However, the GaI4IMSX-1 polypeptides that contained combinations of these segments were effective repressors in both cell lines (Fig. 6A) . For instance, in NIH 3T3 cells, I + II repressed transcription by -lO-fold, I + II + III repressed transcription by -17-fold and IV + V repressed transcription by -7-fold (Fig. 6A) . In fact, the repressor activity ofI + II + III was significantly enhanced in the C2C12 cells (approximately 60-fold) compared to NIH 3T3 cells (about 15-fold). These findings suggest that repression by MSX-1 is mediated by the coordinate action of multiple polypeptide segments in both the N-and C-terminal regions. Moreover, the observation that the N-terminal region is particularly effective in C2C 12 cells is noteworthy, since this myoblast derivative may mimic an appropriate cellular milieu for MSX-l function.
Similar to the GaI4IMSX-1 polypeptides, the Ga14/ MSX-2 polypeptides containing individual segments of the N-or C-termini (i.e., I, II, III or IV) exhibited limited transcriptional activity in either cell line (Fig. 6B) . The exception was segment V, which repressed transcription five-to ten-fold when tested individually, and five-to 17-fold when combined with segment IV (Fig. 6B) . However, the GaI4IMSX-2 polypeptides containing multiple segments of the N-terminal region differed from the corresponding GaI4IMSX-1 polypeptides (compare Fig. 6A and 6B). Specifically, whereas a polypeptide containing segments I + II of MSX-2 repressed transcription effectively (about five-to 12-fold), a polypeptide containing I + II + III had diminished repressor activity (about twoto three-fold) (Fig. 6B ). As shown in Fig. 6C , the Ga14/ MSX-l and GaI4IMSX-2 polypeptides containing these pertinent regions (i.e. I + II, I + II + III) were expressed at equivalent levels in mammalian cell extracts. Western blot analysis of the other fusion polypeptides showed similar levels of protein expression (data not shown). These findings demonstrate a noteworthy difference in the transcriptional properties of MSX-l and MSX-2, in that segments III have opposing functions. In MSX-I, this region potentiates repressor function, while in MSX-2, this region abrogates repressor action. It is noteworthy that this segment corresponds to the same region that distinguishes the relative DNA binding affinities of MSX-l and MSX-2 (see Figs. 2A and 4A,B) .
The MSX homeodomain has intrinsic repressor activity
If MSX proteins do not require homeodomain DNA binding sites for their transcriptional activity, then what role does the homeodomain play in MSX function? To address this question, we examined whether the homeodomain contributes to the transcriptional properties of MSX-l by testing its activity in the context of the Gal4 DNA binding domain (Fig. 7) . Since the MSX-l homeodomain is essentially identical to that of MSX-2 and other MSX proteins (see Fig. 1 ), it serves as a prototype for the MSX family. When tested in NIH 3T3 cells, the Gal4IMSX homeodomain (i.e., GaI4IMSX-I(157-233)) repressed transcription of a reporter plasmid that contained the Gal4 sites, but did not repress transcription of a reporter plasmid that lacked these sites (Fig. 7) . This finding demonstrates that the homeodomain contributes directly to repression by MSX-l and suggests an alternative role in transcriptional regulation distinct from its DNA binding activity.
Expression of Msx-l and Msx-2 is overlapping but not identical
Given the similar biochemical properties of the MSX-l and MSX-2 proteins, we were interested in further examining the extent of overlap in their expression patterns. Although many reports have previously described the expression patterns of Msx-l and Msx-2 using in situ hybridization to paraffin sections of various embryonic tissues (Hill et aI., 1989; Robert et aI., 1989 Robert et aI., , 1991 Coelho et aI., 1991; MacKenzie et aI., 1991a MacKenzie et aI., ,b, 1992 Suzuki et aI., 1991; Yokouchi et aI., 1991; Lyons et aI., 1992; Nishikawa et aI., 1994) , the expression of these two genes has not been previously compared by whole-mount in situ hybridization. Therefore, we utilized this technique to compare Msx-l and Msx-2 expression in mouse embryos from days 7.5 to 13.5 post coitum.
At day 7.5 of gestation, during late stages of gastrulation, the expression patterns of Msx-l and Msx-2 are very similar, both being expressed in broad stripes that corre- Fig. 6 . The N-terminal domains of MSX-l and MSX-2 contribute differently to repressor function. (A,B) Truncated MSX-l and MSX-2 polypeptides contain the amino acids shown in parentheses and correspond to the protein regions represented in the boxes (I-V); these regions were fused to the yeast Gal4 DNA binding domain (Ga14, stippled box). Transfection assays were performed in NIH 3T3 or C2Cl2 cells using a luciferase reporter plasmid (2 p,g) that contained the SV 40 promoter (stippled box) and five tandem copies of the Gal4 DNA binding site (5 x GaI4). Expression plasmids encoding the Gal4IMSX fusion polypeptides were included at 500 ng each. Data are expressed as the fold-difference in luciferase activity obtained with the indicated expression plasmid, relative to the activity obtained with the expression plasmid containing only the Gal4 DNA binding domain. The boxed x-axes highlight the difference in scale between the graphs. The data shown are the compilation of four separate experiments performed in duplicate; the error bars indicate the standard deviation. (C) Western blot analysis was performed using extracts prepared from COS-l cells that were transfected using the expression plasmid without an MSX insert (cell extract) or using the expression plasmids (1.0 p,g) encoding the indicated Gal4IMSX fusion polypeptides. The anti-Gal4 monoclonal antibody (Santa Cruz Biologicals) is directed against an epitope within the Gal4 DNA binding domain. .. spond to the posterior lateral plate mesoderm (Fig. SA,B) . At day 9.5 of gestation, however, discrete differences can be observed between the expression patterns of these two genes (Fig. SC,D) . While both Msx-J and Msx-2 are expressed in the dorsal midline as well as the forelimb bud, the expression of Msx-J is clearly broader in extent in these regions. ' This pattern of overlapping expression continues at day 11.5, when both genes are expressed in the dorsal midline, craniofacial primordia, and developing limb buds (Fig. SE,F) . Notably, however, Msx-J expression is observed in the auditory hillocks, where Msx-2 expression is completely absent (Fig. SE,F) . In the craniofacial primordia, Msx-J is expressed more widely in the distal regions of the nasal processes and the maxillary and mandibular components of the first branchial arch (Fig.  SG,H) . Overall, therefore, we have found that Msx-J and Msx-2 are expressed in similar embryonic regions, with Msx-l expressed in a broader spatial domain than Msx-2, which is consistent with previous reports (Robert et aI., 1991 ; MacKenzie et aI., 1992; Nishikawa et aI., 1994) . During limb bud development, Msx-l has been previously shown to be expressed at high levels in the distal mesenchyme (progress zone) underlying the apical ectodermal ridge (AER), where it is expressed at lower levels (Hill et aI., 19S9; Robert et aI., 19S9, 1991; Coelho et aI., 1991) . In contrast, Msx-2 expression has been observed primarily in the AER and the anterior limb bud mesoderm (Yokouchi et aI., 1991; Coelho et aI., 1991; Sumoy et aI., 1995) . By whole-mount in situ hybridization, we have found that Msx-l is expressed symmetrically throughout the distal mesenchyme (Fig. SI) . By comparison, Msx-2 is expressed asymmetrically, with higher levels in the anterior limb bud margin, as well as in the proximal mesenchyme (Fig. SJ) ; this expression pattern is broader than that recently described using whole-mount in situ hybridization (Sumoy et aI., 1995) . Despite these significant differences in limb expression at day 11.5 of gestation, by day 13.5, Msx-J and Msx-2 are expressed in a relatively similar manner in the interdigital mesenchyme of the foot-plate (Fig. SK,L) .
Taken together, our observations have confirmed and extended previous descriptions of the overlapping expression patterns of Msx-J and Msx-2. Thus, these genes are expressed in spatial domains that permit functional compensation, and as discussed below, may synergize to promote the high fidelity function of the Msx genetic pathway.
Discussion
In this report, we have compared the properties of two members of the murine MSX homeodomain family, MSX-l and MSX-2. We have shown that both protein products bind to DNA with similar specificity, and function as transcriptional repressors independently of homeodomain DNA binding sites. Despite these similarities, these proteins are distinguished by different N-terminal regions that contribute to the enhanced DNA-binding affinity of MSX-2, and to the greater potency of repression by MSX-l. Moreover, although both Msx genes are expressed in overlapping patterns during murine embryogenesis, discrete differences in their expression patterns are evident in specific embryonic tissues. As a result, these two Msx family members appear 'equivalent but not equal' in terms of their biochemical properties and their developmental expression, suggesting a potential mechanism for their proposed functional redundancy.
3.J. The biochemical differences between MSX-J and MSX-2 may be mediated by distinct protein-protein inte rac tions
It is intriguing that the N-terminal regions of MSX-l and MSX-2 modulate their functional properties in opposing ways. For MSX-l, this region reduces DNA binding affinity but enhances repressor function, whereas for MSX-2, this region enhances DNA binding affinity while reducing repressor function . The differences in these functional properties map to a region without a predominant motif; however, MSX-I does contain a 12 amino acid hydrophobic stretch that is not present in MSX-2 (Fig. 9 ). At present, it is unclear what role is served by interaction of MSX proteins with their consensus DNA binding site, since DNA binding is apparently not required for their transcriptional function. However, such an inverse correlation has been previously observed for DNA binding and transcriptional potency among homeodomain proteins (Han and Manley, 1993a,b; Catron et ai., 1995; Schnabel and Abate-Shen, unpublished results) . It is interesting to speculate that interactions with homeodomain DNA sites may serve some alternative function, such as sequestering MSX proteins from their target genes. If this is the case, the reduced DNA binding capacity of MSX-1 may contribute to its enhanced repressor function, whereas MSX-2 would presumably be sequestered more efficiently and therefore be a less effective repressor. Clearly, it will be important in future studies to reconcile the precise role of homeodomain DNA binding activity with the functional consequences of MSX action.
Msx-l Msx-2
Our observations suggest that the ability of two MSX proteins to repress transcription independently of homeodomain binding sites may be a general feature of this protein family. The implication of this finding is that an alternative mechanism directs MSX proteins to their respective target genes. This notion is supported by the observation that targeting MSX to a specific promoter via the Gal4 DNA-binding domain significantly enhanced its repressor function. A likely mode of target gene selection is through protein-protein interactions, which have been indicated as having functional consequences for other homeodomain proteins (Stern et ai., 1989; Pomerantz et ai., 1992; Zappavigna et ai., 1994; Chang et ai., 1995) and for transcription factors in general (Jain et ai., 1993; Kerr et ai., 1993; Liu et ai., 1993; Wagner and Green, 1993;  Msx-l Msx-2 Caudal view of day 7.5 embryos (at the late head-fold stage of Downs and Davies (1993) , under bright-field illumination. Msx-1 and Msx-2 display similar staining patterns in the posterior lateral plate mesoderm (arrow in (B». In both cases, the lateral bands of expression begin just rostral to the node, and meet caudally at the base of the allantois. Expression can also be detected in the chorion (arrowhead) and in the lateral margins of the headfolds, which will later join together to form the cranial dorsal midline (not shown). (C,D) Lateral view of day 9.5 embryos (stage 15 of Theiler (1989) , under combined bright-field and dark-field illumination. Msx-1 is more broadly expressed in the dorsal midline (arrow in (C» and in the forelimb bud (arrowhead). (E,F) Lateral view of day 11.5 embryos (Theiler stage 19) , under dark-field illumination, showing staining in the limb buds, dorsal midline, and craniofacial primordia. Expression of Msx-1, but not Msx-2, is found in the auditory hillocks (arrow) flanking the first branchial cleft, which are destined to form the pinna of the ear (Kaufman, 1992) -133) , which was generated using the PILEUP Program (Genetics Computer Group), with numbering corresponding to the MSX-I sequence. In the MSX-2 sequence, asterisks (*) indicate amino acids that are identical in MSX-I and dots (.) indicate gaps in the sequence alignment. The box indicates the region that contributes to the observed differences in repressor activity and relative DNA binding affinity. Xue et aI., 1993) . The potential for MSX proteins to mediate their functional properties through interactions with other factors adds an additional level of complexity, as well as specificity, to their role in transcriptional regulation. For instance, the accentuated repressor action of the N-terminal region of MSX-l in C2C12 cells may be due to interactions with protein factors that are expressed in these cells but not NIH 3T3 cells. Therefore, the identification of proteins that interact with non-conserved domains of members of the MSX family will likely provide insight into their mode of target selection and their functional consequences. Given that MSX proteins regulate transcription independently of homeodomain DNA binding, one primary issue concerns the actual role of the homeodomain in transcriptional control. We have shown that the MSX homeodomain functions directly as a repressor domain and that this property is distinct from its function as a DNA binding domain. This finding suggests that the MSX homeodomain has a broader role in transcriptional control, and that it may also mediate protein-protein interactions. In fact, we have shown that MSX-l interacts with a component of the general transcription machinery to repress transcription (Catron et aI., 1995) , and we have recently demonstrated that this interaction is mediated by specific residues within the homeodomain (Zhang et aI., 1996) Other reports have also demonstrated the importance of homeodomain-homeodomain interactions in transcriptional regulation. For example, transcriptional activity of HOX D9 is modulated by heterodimer formation with HOX D8, which interact through the N-terminal arm and helix I of their homeodomains (Zappavigna et aI., 1994) . In addition, PBXl forms heterodimers with a subset of HOX proteins through homeodomain interactions, resulting in cooperative DNA binding activity (Chang et aI., 1995; Johnson et aI., 1995; Lu et aI., 1995) . It is therefore likely that the ability of the homeodomain to function via alternative modes of action is a general feature of this conserved motif.
The functional redundancy of MSX proteins may be achieved through distinct biochemical properties
In formal genetic terms, functional redundancy of two gene products can be ascertained through the analysis of double null mutants (Thomas, 1993) . Double mutants for functionally redundant gene products should display synergistic phenotypes for an affected developmental process, possessing new defects in comparison with the additive combination of the single mutant phenotypes. Thus, evidence for partial redundancy of Msx-l and Msx-2 functions has been provided by studies of mice carrying homozygous null mutations for these genes. The Msx-l null phenotype revealed specific defects in derivatives of the first branchial arch, but not in other structures where the gene is expressed, such as the limb buds, neural tube, or endocardium of the heart (Satokata and Maas, 1994) . Notably, a primary defect was observed in the dental follicle mesenchyme, where Msx-2 is not expressed (Satokata and Maas, 1994) . This result suggested that Msx-2 (or another family member) might compensate for the loss of Msx-l activity in many tissues where their expression normally overlaps. Indeed, the double null mutant for Msx-l and Msx-2 possesses a far more severe phenotype than either null mutant individually, displaying morphological alterations in limb and heart development that are not observed in the single null mutants (R. Maas, personal communication). Similar experiments have been used to deduce the functional redundancy of other vertebrate homeobox genes, such as paralogous genes of the Hox clusters (Condie and Capecchi, 1994; Davis et aI., 1995) , and other transcriptional regulators such as myoD and myf-5 (Rudnicki et aI., 1993) .
Our analysis of the biochemical properties and expression patterns of Msx-l and Msx-2 allows us to consider the molecular basis of their redundant genetic functions. Since these two genes encode products that possess similar biochemical properties, and are expressed in a spatially and temporally overlapping pattern, one possi-bility is that the functional redundancy of Msx-1 and Msx-2 promotes high fidelity for an important developmental process, such as epithelial-mesenchymal interactions. This type of functional redundancy is probably commonly employed to achieve fidelity in critical cellular and developmental processes, such as DNA replication, cell cycle control, and gastrulation (Thomas, 1993) . Under conditions of environmental stress or other epigenetic burdens, such functional redundancy might result in greater ability to maintain normal developmental processes, thereby acting as a 'fail-safe' mechanism.
If this is the case for Msx-1 and Msx-2, our biochemical data may provide insight into the molecular basis for a high fidelity redundant process. We have found that these two members of the Msx gene family exhibit similar but non-identical transcriptional functions, which are mediated in part by differing protein domains. Consequently, we propose that the genetic redundancy of Msx-1 and Msx-2 may be achieved through the differential utilization of these protein domains. Since these domains likely interact with distinct protein factors to confer transcriptional repression, an additional level of safeguard control could be provided for the function of the Msx genetic pathway. In this way, potential errors of the Msx pathway during development may be averted, not only by the redundancy of these regulatory genes themselves, but also through their distinct biochemical interactions.
Experimental procedures
Bacterial expression plasm ids
The plasmid containing the full length Msx-1 sequence in the bacterial expression vector pDS56 was described in Catron et ai. (1995) ; that encoding Msx-1(l57-233) was described in Catron et al. (1993) . The plasmid encoding full length Msx-2 was constructed by PCR amplification of an Msx-2 cDNA, using oligonucleotides that correspond to the 5' and 3' flanking regions. These primers contained a BamHI (5') or HindlII (3') restriction site, and the resulting PCR product was subcloned into the corresponding sites in pDS56, as in Catron et al. (1993) . Plasmids encoding the truncated MSX-l and MSX-2 polypeptides were also constructed in pDS56 by PCR amplification using 5' and 3' oligonucleotides that contained BamHI and HindlII sites. The sequence of each Msx expression plasmid was verified using a Sequenase Version 2.0 DNA Sequencing Kit (USB). The hexahistidine fusion proteins were expressed in Escherichia coli, and purified by affinity chromatography on a nickel-affinity resin . Purity was determined to be in the range of 70-90% by Coomassie Blue staining of an SDSpolyacrylamide gel (Fig. 2B) . Protein concentration was determined using a Bradford protein assay and also by absorbance at 280 nm. The percentage of appropriately folded protein was determined by circular dichroism analysis as described in Pellerin et al. (1994) .
Eukaryotic expression plasm ids
The plasmid containing full length Msx-1 in the mammalian expression plasmid pCB6+ was described previously (Catron et ai., 1995) . The plasmid containing full length Msx-2 in pCB6+ was constructed by subcloning the EcoRI-HindIII fragment from pDS56-Msx-2 into the corresponding sites of pCB6+·. The plasmids encoding the Gal4IMSX fusion polypeptides (the pM2-Msx series) were constructed by subcloning the appropriate sequences of Msx-l or Msx-2 into the BamHI and HindIII sites of plasmid pM2 (Sadowski et ai., 1992) . The pM2 plasmids containing full length Msx-1, and Msx-1(226-297) were described in Catron et al. (1995) . The other Msx fusion sequences were constructed by PCR amplification of appropriate regions of Msx-1 or Msx-2 using oligonucleotides that contained a 5' BamHI site or a 3' HindlII site, followed by cloning of the products into the corresponding sites of pM2. This cloning strategy produced expression plasmids that contain the Msx sequences in frame with those encoding the Gal4 DNA binding domain, as verified by DNA sequencing. The expression of each MSX protein in mammalian cells was confirmed by Western blot analysis (Figs. 5B,D and 6C, and data not shown), as described (Catron et ai., 1995) . Each of the proteins were expressed at similar levels in COS-l cells. The antisera used were: anti-MSX-l(157-233), which cross-reacts with MSX-2 (K. Catron and C. Abate-Shen, unpublished results), and anti-Gal4 (Santa Cruz Biologicals).
Transient transfection of NIH 3T3 and C2C12 cells
The reporter plasmid containing the SV40 early promoter driving luciferase gene expression and the Gal4 DNA binding sites was previously described (Catron et al., 1995) . The reporter plasmids containing a genomic fragment from the wntl enhancer (termed WIP) or a mutated version of this fragment (termed mWIP) were described in Her et al. (1995) (mWIP is equivalent to mHBS 1 + 2). All plasmids used in transfection assays were purified using Qiagen Plasmid Kits (Qiagen) according to the manufacturer's instructions. Procedures for maintenance of NIH 3T3 cells and for transfection assays were as described (Catron et ai., 1995) . C2C12 cells were grown in DMEM (high glucose, 25 mM HEPES, without sodium pyruvate) supplemented with 20% FBS. Cells were seeded at 2.5 X 10 4 cells per 35 mm dish prior to transfection. All transfection assays were performed in duplicate and repeated at least three times. A plasmid encoding ,a-galactosidase was included as an internal control in all transfections and transfection efficiency was monitored by measuring ,a-galactosidase activity.
